The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,746.00
Bid: 1,746.00
Ask: 1,746.50
Change: 12.50 (0.72%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: UK Banks Fall After Barclays Posts Profit Drop

Thu, 18th Feb 2021 12:12

(Alliance News) - Stock prices in London continued to slide at midday on Thursday amid concern that a revival in inflation might hold back economic recovery, while UK banks were lower after Barclays annual results disappointed investors.

London's blue-chip index was down 51.34 points, or 0.7%, at 6,659.56. The FTSE 250 index was down 44.92 points, or 0.3%, at 21,103.97, and the AIM All-Share index was flat at 1,222.95.

The Cboe UK 100 index was down 0.1% at 662.81 points. The Cboe 250 was down 0.1% at 18,662.02. The Cboe Small Companies was trailing, down 0.9% at 1,212.36.

The CAC 40 index in Paris was down 0.4% and Frankfurt's DAX 30 was 0.1% lower.

"It has been a lacklustre morning so far as traders continue to be a little cautious about US government bond yields, even though the closely watched 10 year yield has dipped. Like with yesterday, there are minor concerns that US yields could spike due to chatter that inflation is set to rise because of all the various stimulus packages. Upward moves in yields is likely to spark speculation about higher interest rates - something that central banks don't even want to think about for the foreseeable future," said CMC Markets analyst David Madden.

In the FTSE 100, Ashtead Group was the best performer, up 3.1% after Goldman Sachs started coverage on the equipment rental firm with a Buy rating, saying the equipment rentals firm offers strong medium-term growth potential, despite the stock trading at record highs.

"We think there is room for further re-rating as we believe we are at the beginning of an upgrade cycle supported by improving cyclical trends," analysts at the US bank said.

At the other end of the large-caps, Smith & Nephew was still the worst performer, 5.1% lower, but recouping some of its earlier losses. The medical devices maker reported a fall in annual earnings, as the coronavirus pandemic caused elective surgical procedures to be put on hold.

For 2020, revenue was down 11% to USD4.56 billion from USD5.14 billion in 2019, and trading profit fell sharply to USD683 million from USD1.17 billion. The company declared a full-year dividend of 37.5 US cents per share, unchanged from 2019.

Looking ahead to 2021, Smith & Nephew said its outlook reflects the likely continuation of Covid-19 effects during the first half of 2021 and the uncertainty regarding the timing and pace of recovery.

Imperial Brands, GlaxoSmithKline, BP and Royal Dutch Shell 'A' and 'B' shares were down 5.0%, 3.0%, 2.4%, 2.3% and 2.2% respectively. The stocks went ex-dividend, meaning new buyers no longer qualify for the latest payout.

Shell had said Wednesday it has agreed to sell Duvernay shale light oil assets in Canada to Crescent Point Energy. Toronto-listed Crescent will pay USD707 million for the assets, USD550 million in cash and USD157 million worth of shares in the company.

Shares in UK banks were lower after Barclays kicked off sector earnings season. NatWest Group reports on Friday and Lloyds Banking Group on Wednesday next week.

NatWest was 2.5% lower. The Financial Times reported that the UK state-backed lender is gearing up to gradually withdraw from the Republic of Ireland, with the aim of freeing up capital and moving completely to the UK market.

Lloyds was off 3.8%.

Barclays was down 4.7% after reporting a drop in annual earnings - with profit falling by almost a third in 2020.

However, Barclays said it will resume dividend payments after the Bank of England lifted its ban on shareholder distributions in December.

For 2020, Barclays posted net income of GBP21.77 billion, up 1% from GBP21.63 billion in 2019, as net interest income fell 14% to GBP8.12 billion from GBP9.41 billion.

Barclays booked GBP4.84 billion in credit impairments in 2020, more than doubled from GBP1.91 billion in 2019.

Pretax profit sank 30% to GBP3.07 billion from GBP4.36 billion. However, the figure beat company-compiled consensus which forecast pretax profit of GBP2.81 billion.

Barclays declared a dividend of 1.0 pence for 2020, down from 3.0p paid in 2019. In addition, Barclays said it intends to initiate a share buyback of up to GBP700 million, which is expected to commence in the first quarter of 2021.

"On the face of it you might have expected a round of applause for Barclays fourth-quarter results which were significantly better than forecast and came with the extra cherry of a reinstated dividend, bolstered by a share buyback. Instead the company got the cold shoulder from the market as attention was drawn by large provisions on Covid-related bad debt and a warning of a continuing impact through the course of 2021," said AJ Bell's Russ Mould.

"While allowing banks to pay dividends for the year just gone, the regulator has stipulated that any dividends for 2021 have to be accrued rather than doled out, at least until it's had a chance to reassess the position the economy and financial situation is in over the summer. In other words there's no absolute guarantee the usual first-half dividend will be paid,'' Mould added.

The dollar was lower against major counterparts after dovish meeting minutes from the US Federal Reserve. The pound was quoted at USD1.3945 at midday Thursday, up sharply from USD1.3845 at the London equities close Wednesday.

The euro was priced at USD1.2070, higher against USD1.2036. Against the yen, the dollar was trading at JPY105.64, down from JPY105.82.

The US economy is "still far" from the Fed's goals, the minutes released on Wednesday showed, and it is likely to take "some time" before further progress towards the central bank's employment and inflation targets is achieved.

Analysts at ActivTrades said: "After gaining ground to other major currencies during the first half of the week, the US dollar is on the back foot during the start of Thursday's trading session. This change in dynamic came after the publication of the minutes for the Federal Reserve's last meeting, where it became clear that despite the central bank's optimistic expectations for economic growth in 2021, it has no intention to review its accommodative monetary policy or purchase program.

"The topic of inflation has recently been trending amongst investors, with many selling low coupon bonds and driving a rise in yields and subsequently increasing dollar demand, as they moved to price in a potential change of stance from the Fed. However, the Fed has no such concerns and, according to the minutes published yesterday, appears determined to maintain its current course of very low interest rates and large bond purchases, which creates scope for further dollar weakness.''

Brent oil was quoted at USD64.56 a barrel Thursday at midday, up sharply from USD63.53 late Wednesday, as US refining and extraction capacity remains shuttered due to deadly wintry conditions in Texas. The North Sea benchmark had breached the USD65 mark for the first time in over a year in early trade. The US benchmark WTI spot price was quoted USD61.45, higher against USD60.39.

Texas Governor Greg Abbott directed the Lone Star state's natural gas providers not to ship outside the state until Sunday and asked the state energy regulator to enforce the export ban.

"Oil prices rose to fresh 13-month highs as traders bet shut-ins in Texas will affect oil producers and refiners for a while longer. It's estimated that US crude output is down by as much as 3.5 million barrels per day as freezing temperatures and power outages have hit the Permian Basin," said Markets.com analyst Neil Wilson.

Gold was trading at USD1,786.25 an ounce, higher versus USD1,774.53 at the London equities close on Wednesday.

US stock market futures were pointed to a lower open as US lawmakers open a hearing Thursday seeking answers on the recent stock market frenzy that caused dizzying moves in the value of little-known shares and prompted calls for tougher Wall Street regulations.

The Dow Jones Industrial Average was called down 0.3%, the S&P 500 down 0.5% and the Nasdaq Composite down 0.8%.

The House Financial Services Committee was to hear from witnesses playing a role in the volatility affecting video game retailer GameStop and other companies in recent weeks. The unprecedented volatility prompted calls for regulators to review the role of social media, hedge funds and trading platforms which may manipulate the market.

In prepared testimony, Robinhood CEO Vladimir Tenev defended the actions of his company which enables free trades to small investors.

"Any allegation that Robinhood acted to help hedge funds or other special interests to the detriment of our customers is absolutely false and market-distorting rhetoric," Tenev said.

In the economic calendar for Thursday, there is US initial jobless claims at 1330 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.